Attenuation of Induced Oxidative Stress and Neurological Deficit in Tramadol Use by Co-administration with Ribena Drink and Vitamin E in Male Wistar Rats

Igben Onoriode Vincent_Junior

Department of Pharmacology and Therapeutics, Delta State University, Abraka, Nigeria.

Isibor Anwuli Promise

Department of Human Anatomy and Cell Biology, Delta State University, Abraka, Nigeria.

Okoro Ogheneyebrorue Godswill *

Department of Human Anatomy, University of Delta, Agbor, Nigeria.

Isioma Cynthia Nwaokoro

Department of Human Anatomy, University of Delta, Agbor, Nigeria.

Obohwemu Oberhiri Kennedy

Department of Health, Wellbeing and Social Care, Global Banking School/Oxford Brookes University, Birmingham, United Kingdom.

Kaine Omashim Oluwakemi

Department of Human Anatomy and Cell Biology, Delta State University, Abraka, Nigeria.

Egwunyenga Michael Oge

Department of Human Anatomy and Cell Biology, Delta State University, Abraka, Nigeria.

George Kelvin Nkem

Department of Human Anatomy, University of Delta, Agbor, Nigeria.

Nicholas Asiwe

Department of Human Anatomy, University of Delta, Agbor, Nigeria.

Osadjere Oghenekevwe Sonia

Department of Human Anatomy and Cell Biology, Delta State University, Abraka, Nigeria.

Obie Rukevwe

Department of Human Anatomy and Cell Biology, Delta State University, Abraka, Nigeria.

Anthonia Oshaye Uku

Department of Pharmacology and Therapeutics, Delta State University, Abraka, Nigeria.

John Chinedu Obianke

Department of Human Anatomy, University of Delta, Agbor, Nigeria.

Eboka Olisaemeka Ifechukwude

Department of Human Anatomy, University of Delta, Agbor, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Tramadol appears to exert its analgesic effect by binding to the μ‑opioid receptor (MOR) and modulating the noradrenergic, serotonergic activities as a serotonin‑norepinephrine reuptake inhibitor, and also, gamma‑aminobutyric acid (GABA) ‑ergic system. These multiple effects on different neurotransmitter systems can complicate the effects of tramadol and its addiction. It has been established that tramadol addiction is associated with structural and functional changes in prefrontal cortex. However, the mechanism through which these changes are induced is not clear. The aim of this study is to determine the attenuation of induced oxidative stress and neurological deficit in tramadol use by co-administration with ribena drink and vitamin E in male Wistar rats. Prior to this study, the Ethical Committee of the Faculty of Basic Medical Sciences, Delta State University, Abraka, Nigeria, assessed the procedure for experiments in this study and approved it in tandem with the regulatory policy for the use of animals for research purposes with Ethical no: REC/FBMS/DELSU/21/88. Forty male wistar rats (22.0±2.0 g) were divided into group A (control) received deionized water 2mls/kg/bw, treatment groups, group A: Tramadol 50mg/kg/bw, group B: Tramadol + Ribena 2mls/kg group C: Tramadol (50mg/kg) + Ribena (2mls/kg), group D: Tramadol (50mg/kg) + Ribena (2mls/kg) + Viatmin E (100mg/kg) orally administered daily for 28days. Motor functions as well as brain oxido stress biomarkers, was assessed. Histological sections of the motor cortex were also examined and the data analyzed using descriptive statistics and Anova at p=0.05. Oral exposure to tramadol induces behavioral deficits, with no histoarchitectural changes in the prefrontal cortex, however, Vitamin E and Ribena possess neuroprotective potential via antioxidant mechanism in the brain of rats. These observations confirm the neuroprotective and beneficial effects and therapeutic effect.

Keywords: Ribena, tramadol, prefrontal cortex, vitamin E


How to Cite

Vincent_Junior, Igben Onoriode, Isibor Anwuli Promise, Okoro Ogheneyebrorue Godswill, Isioma Cynthia Nwaokoro, Obohwemu Oberhiri Kennedy, Kaine Omashim Oluwakemi, Egwunyenga Michael Oge, et al. 2025. “Attenuation of Induced Oxidative Stress and Neurological Deficit in Tramadol Use by Co-Administration With Ribena Drink and Vitamin E in Male Wistar Rats”. Asian Journal of Research in Medical and Pharmaceutical Sciences 14 (2):1-12. https://doi.org/10.9734/ajrimps/2025/v14i2301.

Downloads

Download data is not yet available.